Stockscreener 앱 받기
15.65
1.14%
-0.18
시장 영업 전:
15.62
-0.03
-0.19%
Arcutis Biotherapeutics Inc 주식(ARQT)의 최신 뉴스
Using data filters to optimize entry into Arcutis Biotherapeutics Inc.Gold Moves & Capital Efficiency Focused Strategies - Newser
What momentum shifts mean for Arcutis Biotherapeutics Inc.Earnings Risk Summary & Risk Controlled Swing Trade Alerts - Newser
Will Arcutis Biotherapeutics Inc. rebound enough to break evenJuly 2025 Closing Moves & Technical Analysis for Trade Confirmation - Newser
Understanding Arcutis Biotherapeutics Inc.’s price movementQuarterly Market Review & Momentum Based Trading Signals - Newser
Chart based analysis of Arcutis Biotherapeutics Inc. trendsTrade Signal Summary & Entry Point Strategy Guides - Newser
Will Arcutis Biotherapeutics Inc. continue its uptrendJuly 2025 Recap & Advanced Technical Signal Analysis - Newser
Applying big data sentiment scoring on Arcutis Biotherapeutics Inc.Quarterly Performance Summary & Fast Moving Market Watchlists - Newser
Can you recover from losses in Arcutis Biotherapeutics Inc.July 2025 Breakouts & Precise Trade Entry Recommendations - Newser
Live market analysis of Arcutis Biotherapeutics Inc.Portfolio Profit Report & Real-Time Volume Trigger Notifications - Newser
Arcutis Biotherapeutics Inc. stock retracement – recovery analysis2025 Major Catalysts & Fast Exit and Entry Strategy Plans - Newser
Is Arcutis Biotherapeutics Inc. reversing from oversold territoryJuly 2025 PreEarnings & Community Shared Stock Ideas - Newser
Published on: 2025-08-27 10:54:22 - Newser
Is Arcutis Biotherapeutics Inc. still worth holding after the dipJuly 2025 Trends & Intraday High Probability Alerts - Newser
Is Arcutis Biotherapeutics (ARQT) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
What’s next for Arcutis Biotherapeutics Inc. stock priceWeekly Trend Summary & Verified Momentum Stock Ideas - Newser
Will Arcutis Biotherapeutics Inc. price bounce be sustainableMarket Movers & Fast Entry High Yield Tips - Newser
What technical models suggest about Arcutis Biotherapeutics Inc.’s comeback2025 Analyst Calls & Risk Managed Investment Signals - Newser
3 Biotech Catalysts Present Major Opportunity - Investing.com
Combining machine learning predictions for Arcutis Biotherapeutics Inc.Watch List & Fast Entry Momentum Alerts - Newser
Three Biotech Companies to Watch: Boston Scientific, Arcutis Biotherapeutics, and Incyte Corporation - AInvest
Sentiment Turns Positive on Arcutis Biotherapeutics Inc. — Reversal Ahead getLinesFromResByArray error: size == 0 - metrotimes.co.kr
Will breakout in Arcutis Biotherapeutics Inc. lead to full recoveryJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - Newser
3 Biotech Catalysts Present Major Opportunity - MarketBeat
Arcutis Biotherapeutics Stock Scores RS Rating Upgrade - MSN
Published on: 2025-08-24 08:42:48 - Newser
Is Arcutis Biotherapeutics Inc. stock showing strong momentumTrade Exit Report & Low Risk Entry Point Tips - theviewers.co.kr
What recovery options are there for Arcutis Biotherapeutics Inc.2025 Short Interest & Free Growth Oriented Trading Recommendations - Newser
Applying chart zones and confluence areas to Arcutis Biotherapeutics Inc.Breakout Watch & Low Drawdown Momentum Ideas - Newser
How moving averages guide Arcutis Biotherapeutics Inc. tradingEarnings Risk Summary & Reliable Price Breakout Signals - Newser
Arcutis: ZORYVE's Multi-Indication Momentum And Margin Expansion Justify A Bullish Re-Rate - Seeking Alpha
Arcutis’ ZORYVE Receives AAD Recommendation for Adult Atopic Dermatitis - MSN
Will Arcutis Biotherapeutics Inc. announce a stock splitWeekly Trend Summary & Daily Technical Forecast Reports - theviewers.co.kr
Can Arcutis Biotherapeutics Inc. maintain sales growthTreasury Yields & Technical Pattern Recognition Alerts - theviewers.co.kr
Arcutis Biotherapeutics Inc. May Be Forming Higher Low — Chartwatchers AlertWatch List & Weekly High Return Opportunities - classian.co.kr
How volatile is Arcutis Biotherapeutics Inc. stockShare Buyback & Free Low Drawdown Momentum Trade Ideas - kpenews.com
Can Arcutis Biotherapeutics Inc. stock double in the next year2025 Investor Takeaways & Reliable Entry Point Alerts - theviewers.co.kr
Arcutis Biotherapeutics Officer Sells Shares to Cover Tax Obligations - TradingView
Is Arcutis Biotherapeutics Inc. the Top Chart Pick This WeekWeekly Investment Report & Weekly Top Stock Performers List - beatles.ru
Smart tools for monitoring Arcutis Biotherapeutics Inc.’s price action2025 Biggest Moves & Free Reliable Trade Execution Plans - Newser
Arcutis Biotherapeutics Inc. Recovers — But Is It Sustainable2025 Pullback Review & AI Based Buy/Sell Signal Reports - 더경남뉴스
Tick level data insight on Arcutis Biotherapeutics Inc. volatilityPortfolio Value Summary & Short-Term Swing Trade Alerts - Newser
Arcutis Biotherapeutics Inc. Stock Lags Behind Sector BenchmarksMarket Growth Review & Weekly Chart Analysis and Trade Guides - beatles.ru
Arcutis Biotherapeutics Announces Participation in Upcoming Investor Conferences - AInvest
Arcutis to Present at Upcoming Investor Conferences - MarketScreener
Immuno-Dermatology Leader Arcutis Lines Up Triple Conference Presence: Citi, Morgan Stanley & HC Wainwright - Stock Titan
AI Tools Suggest Arcutis Biotherapeutics Inc. May Outperform This WeekJuly 2025 Big Picture & Risk Adjusted Buy and Sell Alerts - beatles.ru
Will Arcutis Biotherapeutics Inc. bounce back from current supportJobs Report & Growth Oriented Trading Recommendations - Newser
Analyzing recovery setups for Arcutis Biotherapeutics Inc. investorsJuly 2025 Trade Ideas & Safe Entry Point Alerts - Newser
0.98%
8.06%
자본화:
|
볼륨(24시간):